Alvimopan

Expert Opinion on Investigational Drugs

Volumn 14, Issue 4, 2005, Pages 479-488

  Neary, Paul ^a   Delaney, Conor P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

ADL 8 2698; Alvimopan; Entereg ; Opioid antagonist; Opioid induced bowel dysfunction; Post operative ileus

Indexed keywords

ALVIMOPAN; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; LOPERAMIDE; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; OPIATE; PLACEBO;

ABDOMINAL DISTENSION; ABDOMINAL SURGERY; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CLINICAL PRACTICE; CLINICAL TRIAL; CONSTIPATION; CONVALESCENCE; DIARRHEA; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG METABOLISM; DRUG PENETRATION; DRUG SAFETY; DRUG STRUCTURE; DRUG UTILIZATION; DYSPEPSIA; ENTEROPATHY; EVIDENCE BASED MEDICINE; FEVER; FLATULENCE; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACT FUNCTION; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; ILEUS; INSOMNIA; INTESTINE MOTILITY; META ANALYSIS; MOUSE; NAUSEA AND VOMITING; NONHUMAN; PRURITUS; RAT; RECEPTOR AFFINITY; REVIEW; SYSTEMATIC REVIEW; TACHYCARDIA; TREATMENT OUTCOME;

ABDOMEN; ADMINISTRATION, ORAL; ADULT; ANALGESICS, OPIOID; CONSTIPATION; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; HUMANS; ILEUS; MALE; MIDDLE AGED; NARCOTIC ANTAGONISTS; PIPERIDINES; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, OPIOID, MU;

EID: 19044366285     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.14.4.479     Document Type: Review

References (50)

1. LIVINGSTON EH, PASSARO EP: Postoperative ileus. Dig. Dis. Sci. (1990) 35:121-132.
2. PAPPAGALLO M: Incidence prevalence and management of opioid bowel dysfunction. Am. J. Surg. (2001) 182(Suppl.):11S-18S.
3. HANDAL KA, SCHAUBEN JL, SALAMONE FR: Naloxone. Ann. Emerg. Med. (1983) 12:438-445.
4. FOSS J: A review of the potential role of methyl naltrexone in opioid bowel dysfunction. Am. J. Surg. (2001) 182(Suppl. 5a):19S-26S.
5. YUAN CS, FOSS JF, O'CONNOR M et al.: Methylnaltrexone prevents morphine induced delay in oral cecal transit time without affecting analgesia: a double blind randomized placebo controlled trial. Clin. Pharmacol. Ther. (1996) 59:469-475.
6. YUAN CS, FOSS JF, O'CONNOR M et al.: Methylnaltrexone for reversal of constipation due to chronic methadone use. JAMA (2000) 283:367-372.
7. SCHMIDT WK: Alvimopan: (ADL-8-2698) is a novel peripheral opioid antagonist. Am. J. Surg. (2001) 182(Suppl.):27S-38S.
8. KURZ A, SESSLER D: opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs (2003) 63(7):649-671.
9. GUYTON AC, HALL JE: General Principles of gastrointestinal function: motility, nervous control, and blood circulation. In: Textbook of medical physiology. 10th Edition, Philadelphia, USA (2000):793-801.
10. LIVINGSTON EH, PASSARO EP: Postoperative ileus. Dig. Dis. Sci. (1990) 35:121-132.
11. KROMER W: Endogenous opioids, the enteric nervous system and gut motility. Dig. Dis. (1990) 8:361-373.
12. AUSTROP ML, KOREAN G: Analgesic agents for the postoperative period: opioids. Surg. Clin. N. Am. (1999) 79:253-273.
13. ZUCKERMAN LA, FERRANTE FM: Non-opioid and opioid analgesics. In: The management of pain. Ashburn MA, Rice LJ (Eds). Churchill Livingston, New York, USA (1998):111-140.
14. TSENG LF: Evidence for ε-opioid receptor mediated beta-endorphin induced analgesia. Trends Pharmacol. Sci. (2001) 22:623-630.
15. CALO G, RIZZI A, BIGONI R et al.: Pharmacological profile of nociceptin/orphanin FQ receptors. Clin. Exp. Pharmacol. Physiol. (2002) 29:223-228.
16. GREENWALD MK, STITZER ML, HABERNY KA: Human pharmacology of the opioid neuropeptide dynorphin A (1-13). J. Pharmacol. Exp. Ther. (1997) 281:1154-1163.
17. PASTERNAK GW: Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. (1993) 16:1-18.
18. FRANTZIDES CT, COWLES V, SALAYMEH B et al.: Morphine effects on human colonic myoelectrical activity in the postoperative period. Am. J. Surg. (1992) 163:144-149.
19. VANEGAS G, RIPAMONTI C, SBANOTTO et al.: Side effects of morphine administration in cancer patients. Cancer Nurs. (1998) 21:289-297.
20. LIU M, WITTBRODT E: Low dose oral naloxone reverses opioid induced constipation and analgesia. J. Pain Symptom Manage. (2002) 23(1):48-53.
21. CULPEPPER-MORGAN JA, INTURRISSI CE, PORTENOY RK et al.: Treatment of opioid-induced constipation with naloxone a pilot study. Clin. Pharmacol. Ther. (1992) 52:90-95.
22. CHESKIN LJ, CHAMI TN, JOHNSON RE et al.: Assessment of nalmefene glucuronide as a selective gut opioid antagonist. Drug Alcohol Depend. (1995) 39:151-154.
23. YUAN CS: Clinical status of methylnaltrexone a new agent to prevent and manage opioid induced side effects. J. Support Oncol. (2004) 2(2):111-117.
24. FOSS J: A review of the potential role of methyl naltrexone in opioid bowel dysfunction. Am. J. Surg. (2001) 182(Suppl. 5a):19s-26s.
25. YUAN CS, FOSS JF, O'CONNOR M et al.: Methylnaltrexone prevents morphine induced delay in oral cecal transit time without affecting analgesia: a double blind randomized placebo controlled trial. Clin. Pharmacol. Ther. (1996) 59:469-475.
26. YUANCS, FOSS JF, OSINSKI J, TOLEDANO A, ROIZEN MF, MOSS J: The safety and efficacy in preventing morphine-induced delay in oral cecal transit time. Clin. Pharmacol. Ther. (1997) 61:467-475.
27. YUAN CS, FOSS JF, O'CONNOR M et al.: Methylnaltrexone for reversal of constipation due to chronic methadone use. JAMA (2000) 283:367-372.
28. AZODO IA, EHRENPREIS ED: Alvimopan. Curr. Opin. Invest. Drugs (2002) 3(10):1496-1501.
29. ZIMMERMAN DM, GIDDA JS, CANTRELL BE et al.: LY-246736 dihydrate μ-opioid receptor antagonist. Drugs Future (1994) 19:1078-1083.
30. ZIMMERMAN DM, GIDDA JS, CANTRELL BE et al.: Discovery of a potent peripherally selective trans-3,4,dimethyl-4-(3-hydroxyphenyl) piperidine opioid antagonist for the treatment of gastrointestinal motility disorders. J. Med. Chem. (1994) 37:2262-2265.
31. CALI RL, MEADE PG, SWANSON MS, FREEMAN C: Effect of incision length on bowel function after colectomy. Dis. Colon Rectum (2000) 43:163-168.
32. BOKEY L, CHAPUIS PH, FUNG C et al.: Postoperative morbidity and mortality following resection of the colon and rectum for cancer. Dis. Colon Rectum (1995) 38:480-487.
33. DELANEY C: Clinical perspective on postoperative ileus and the effect of opiates. Neurogastroenterol. Motil. (2004) 16(Suppl. 2):61-66.
34. BASSE L, THORBOL JE, LOSSL K, KEHLET H: Colonic surgery with accelerated rehabilitation or conventional care. Dis. Colon Rectum (2004) 47:271-278.
35. JORGENSEN H, WETTERSLEV J, MOINICHE S, DAHL HB: Epidural local anesthetic versus opioid based analgesic regimens on postoperative gastrointestinal paralysis, PONV and pain after abdominal surgery. Cochrane Database Syst. Rev. (2000) 4:CD001893.
36. DELANEY CP, FAZIO VW, SENAGORE AJ, ROBINSON B, HALVERSON AL, REMZI FH: 'Fast Track' postoperative management protocol for patients with high co-morbidity undergoing complex abdominal and pelvic colorectal surgery. Br. J. Surg. (2001) 88:1533-1538.
37. CALLAGHAN JT, CERIMELE B, NOWAK TV et al.: Effect of opioid antagonist LY-246736 on gastrointestinal transit in human subjects. Gastroenterology (1998) 114:G3015.
38. BARR WH, NGUYEN P, SLATTERY M et al.: ADL-8-2698 reverses opioid-induced delay in colonic transit. Clin. Pharmacol. Ther. (2000) 67:93.
39. LIU S, HODGSON P, CARPENTER R, FRICKE JR: ADL-8-2698 a trans-3-,4-dimethyl -4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia. Clin. Pharmacol. Ther. (2000) 68:66-71.
40. TAGUCHI A, SHARMA N, SALEEM RM et al.: Selective postoperative inhibition of gastrointestinal opioid receptors. N. Engl. J. Med. (2001) 345:935-940.
41. WOLFF BG, MICELASSI F, GERKIN TM et al.: Alvimopan, a novel, peripherally acting μ opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, Phase III trial of major abdominal surgery and postoperative ileus. Ann. Surg. (2004) 240(4):728-734.
42. RAO SS, BEATY J, CHAMBERLAIN M, LAMBERT PG, GISOLFI C: Effects of acute graded exercise on human colonic motility. Am. J. Physiol. (1999) 276:G1221-G1226.
43. BASSE L, THORBOL JE, LOSSL K, KEHLET H: Colonic surgery with accelerated rehabilitation or conventional care. Dis. Colon Rectum (2004) 47:271-278.
44. ASAO T, KUWANO H, NAKAMURA J, MORINGA N, HIRAYAMA I, IDE M: Gum chewing enhances early recovery from postoperative ileus after laparoscopic colectomy. J. Am. Col. Surg. (2002) 195:30-32.
45. RIXT, JOURDAN L: 'Fast-track' postoperative management protocol for patients with high co-morbidity undergoing complex abdominal and pelvic colorectal surgery. Br. J. Surg. (2001) 88(11):1533-1538.
46. SENAGORE AJ, DUEPREE HJ, DELANEY CP, BRADY KM, FAZIO VW: Results of a standardized technique and postoperative care plan for laparoscopic sigmoid colectomy: a 30-month experience. Dis. Colon Rectum (2003) 46(4):503-509.
47. FERRAZ AAB, COWLES VE, CONDON RE et al.: Nonopioid analgesics shorten the duration of postoperative ileus. Am. Surg. (1995) 12:1079-1083.
48. PRASAD M, MATTHEWS J: Deflating postoperative ileus. Gastroenterology (1999) 117:489-492.
49. SMITH A, NISSAN A, LANNOUTTE N et al.: Prokinetic effect of erythromycin after colorectal surgery. Dis. Colon Rectum (2000) 43:333-337.
50. NUNLEY JC, FITZHARRIS GP: Postoperative ileus. Curr. Surg. (2004) 61(4):341-345.